Freeline Therapeutics Holdings Plc logo

Freeline Therapeutics Holdings Plc Share Price (NASDAQ: FRLN)

▲

-6.48

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 16 Feb 2024

Check the interactive Freeline Therapeutics Holdings Plc Stock chart to analyse performance

Freeline Therapeutics Holdings Plc Key Stats

Check Freeline Therapeutics Holdings Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.48
Open
$6.49
Market Capitalization
$28.3M
Today's Volume
$5.7K
Revenue TTM
$622.0K
EBITDA
$-64.8M
Earnings Per Share (EPS)
$-11.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-101.26%

Global Institutional Holdings in Freeline Therapeutics Holdings Plc

  • Name

    Holdings %

  • Millennium Management LLC

    8.50%

  • Polygon Management Ltd

    6.12%

  • CHI Advisors LLC

    1.99%

  • Morgan Stanley - Brokerage Accounts

    0.97%

  • UBS Group AG

    0.78%

  • Renaissance Technologies Corp

    0.60%

Analyst Recommendation on Freeline Therapeutics Holdings Plc Stock

Rating
Trend

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Freeline Therapeutics Holdings Plc(by analysts ranked 0 to 5 stars)

About Freeline Therapeutics Holdings Plc

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
Organization
Freeline Therapeutics Holdings Plc
Employees
152
CEO
Mr. Michael J. Parini J.D.
Industry
Health Technology

Important FAQs about investing in FRLN Stock from India :

What is Freeline Therapeutics Holdings Plc share price today?

Freeline Therapeutics Holdings Plc share price today is as on . Freeline Therapeutics Holdings Plc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Freeline Therapeutics Holdings Plc share?

Freeline Therapeutics Holdings Plc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Freeline Therapeutics Holdings Plc stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Freeline Therapeutics Holdings Plc Stock (FRLN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Freeline Therapeutics Holdings Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Freeline Therapeutics Holdings Plc Shares .

What is the minimum amount required to buy Freeline Therapeutics Holdings Plc Stock (FRLN) from India?

Indian investors can start investing in Freeline Therapeutics Holdings Plc (FRLN) shares with as little as ₹88.2013 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Freeline Therapeutics Holdings Plc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Learn more about fractional shares .

What are the returns that Freeline Therapeutics Holdings Plc has given to Indian investors in the last 5 years?

Freeline Therapeutics Holdings Plc stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?